All-In-One Gadolinium–Doxorubicin Nanoassemblies for Spatial Delivery and Chemoresistance Reversal in Tumor Microenvironments
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.4c21725 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Guanyu Ruan und 10 weiteren Autor:innen. Beteiligte Einrichtung: The School of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350001, P. R. China. Hauptthemen laut MEDLINE: Doxorubicin, Drug Resistance, Neoplasm, Tumor Microenvironment, Gadolinium. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Fujian Province, Fujian Provincial Health Technology Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The School of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350001, P. R. China.
- Fujian Maternity and Child Health Hospital College of Clinical Medical College for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian 350001, P. R. China.
- Fujian Center for Safety Evaluation of New Drugs, Fujian Medical University, Fuzhou, Fujian 351004, P. R. China.
- State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian 350002, P. R. China.
- Electron Microscopy Laboratory of Public Technology Service Center, Fujian Medical University, Fuzhou, Fujian 351004, P. R. China.
- Department of Pharmacy, Fuzong Clinical Medical College of Fujian Medical University (900 Hospital of the Joint Logistics Team), Fuzhou, Fujian 350025, P. R. China.
ORCID-Profile: Guanyu Ruan, Lixiang Ye, Jianxi Ke, Hongyu Lin, Zhihong Liu, Yu Fang, Yongsheng Liu
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Fujian Province
- Fujian Provincial Health Technology Project
- National Natural Science Foundation of China
- Fund of Fujian Science & Technology Innovation Laboratory for Optoelectronic Information
- Fujian Joint Funds for the Innovation of Science and Technology
- Self-deployment Project Research Program of Haixi Institutes, Chinese Academy of Sciences
Zitieren
APA
Ruan, G., Ye, L., Ke, J., Lin, H., Wu, M., Liu, Z., Fang, Y., Zhang, S., Wang, H., Liu, Y., & Song, H. (2025). All-In-One Gadolinium–Doxorubicin Nanoassemblies for Spatial Delivery and Chemoresistance Reversal in Tumor Microenvironments. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c21725
Vancouver
Ruan G, Ye L, Ke J, Lin H, Wu M, Liu Z, et al. All-In-One Gadolinium–Doxorubicin Nanoassemblies for Spatial Delivery and Chemoresistance Reversal in Tumor Microenvironments. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c21725
BibTeX
@article{Ruan2025,
author = {Ruan, Guanyu and Ye, Lixiang and Ke, Jianxi and Lin, Hongyu and Wu, Minxia and Liu, Zhihong and Fang, Yu and Zhang, Shuihua and Wang, Hongmei and Liu, Yongsheng and Song, Hongtao},
title = {All-In-One Gadolinium–Doxorubicin Nanoassemblies for Spatial Delivery and Chemoresistance Reversal in Tumor Microenvironments},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.4c21725}
}
EUVIMED